Abstract
There have been few reports on the development of metabolic disorders, especially when they are considered as a cluster. The purpose of this study was to describe risk profiles for metabolic syndrome (MetS) in elderly dwellers in Beijing, and to find their transition patterns over time. Data were derived from Beijing longitudinal study of aging, a community-based cohort study hosted by Xuanwu hospital. There were 3,257 elderly people aged 55 years or over recruited in 1992. MetS was assessed for the years 1992, 2000, and 2009. Finally, 363 subjects with complete information for components of MetS in the three years were included in the study. The criteria of MetS recommended by the joint interim statement criteria were adopted. Latent transition analysis was used to calculate the transition probabilities between adjacent visits. A risk typology consisting of four time-invariant groups was detected based on the components of MetS for all subjects. Low MetS risk group, BP risk group, BP–HDL risk group, and BP–FPG–TG risk group were found. The probability of staying at the same status was higher at the two intervals across 18 years. Four latent groups were extracted based on three assessments for the components of MetS, together with their transition patterns. Findings suggested various trajectories for MetS components. Different combinations of intervention strategy might be needed for MetS risk groups.
Similar content being viewed by others
References
H. Stirnadel, X. Lin, H. Ling, K. Song, P. Barter, Y.A. Kesaniemi, R. Mahley, R. McPherson, G. Waeber, T. Bersot, J. Cohen, S. Grundy, B. Mitchell, V. Mooser, D. Waterworth, Genetic and phenotypic architecture of metabolic syndrome-associated components in dyslipidemic and normolipidemic subjects: the GEMS study. Atherosclerosis 197(2), 868–876 (2008)
H.M. Lakka, D.E. Laaksonen, T.A. Lakka, L.K. Niskanen, E. Kumpusalo, J. Tuomilehto, J.T. Salonen, The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288(21), 2709–2716 (2002)
K. Esposito, P. Chiodini, A. Capuano, G. Bellastella, M.I. Maiorino, D. Giugliano, Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine (2013). doi:10.1007/S12020-013-9973-3
K.C. Sung, S. Ryu, G.M. Reaven, Relationship between obesity and several cardiovascular disease risk factors in apparently healthy Korean individuals: comparison of body mass index and waist circumference. Metabolism 56(3), 297–303 (2007)
N.Y. Li, J. Yu, X.W. Zhang, S.X. Wang, P. Chang, Q. Ding, R.X. Ma, Q.F. Chen, F. Zhao, F. Bai, Features of left ventricular hypertrophy in patients with metabolic syndrome with or without comparable blood pressure: a meta-analysis. Endocrine 43(3), 548–563 (2013)
G.M. Reaven, Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu. Rev. Med. 44, 121–131 (1993)
K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato, J.C. Fruchart, W.P. James, C.M. Loria, S.C. Smith Jr, Harmonizing the metabolic syndrome: a joint interim statement of the international diabetes federation task force on Epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international Atherosclerosis society; and international association for the study of obesity. Circulation 120(16), 1640–1645 (2009)
A. Vonbank, C.H. Saely, P. Rein, H. Drexel, Insulin resistance is significantly associated with the metabolic syndrome, but not with sonographically proven peripheral arterial disease. Cardiovasc. Diabetol. 12, 106 (2013)
K.C. Sung, M.H. Seo, E.J. Rhee, A.M. Wilson, Elevated fasting insulin predicts the future incidence of metabolic syndrome: a 5-year follow-up study. Cardiovasc. Diabetol. 10, 108 (2011)
S.M. Grundy, J.I. Cleeman, S.R. Daniels, K.A. Donato, R.H. Eckel, B.A. Franklin, D.J. Gordon, R.M. Krauss, P.J. Savage, S.C. Smith Jr, J.A. Spertus, Costa Fernando, diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement: executive Summary. Crit. Pathw. Cardiol. 4(4), 198–203 (2005)
C.M. Lee, R.R. Huxley, M. Woodward, P. Zimmet, J. Shaw, N.H. Cho, H.R. Kim, S. Viali, M. Tominaga, D. Vistisen, K. Borch-Johnsen, S. Colagiuri, The metabolic syndrome identifies a heterogeneous group of metabolic component combinations in the Asia-Pacific region. Diabetes Res. Clin. Pract. 81(3), 377–380 (2008)
I. Protopsaltis, G. Nikolopoulos, E. Dimou, P. Brestas, S. Kokkoris, P. Korantzopoulos, A. Melidonis, Metabolic syndrome and its components as predictors of all-cause mortality and coronary heart disease in type 2 diabetic patients. Atherosclerosis 195(1), 189–194 (2007)
S.M. Rodriguez-Colon, J. Mo, Y. Duan, J. Liu, J.E. Caulfield, X. Jin, D. Liao, Metabolic syndrome clusters and the risk of incident stroke: the atherosclerosis risk in communities (ARIC) study. Stroke 40(1), 200–205 (2009)
S. Tanomsup, W. Aekplakorn, P. Sritara, M. Woodward, S. Yamwong, S. Tunlayadechanont, A. Tatsaneeyapan, S. Lim, R. Rajatanavin, A comparison of components of two definitions of the metabolic syndrome related to cardiovascular disease and all-cause mortality in a cohort study in Thailand. Diabetes Care 30(8), 2138–2140 (2007)
S.T. Lanza, L.M. Collins, A new SAS procedure for latent transition analysis: transitions in dating and sexual risk behavior. Dev. Psychol. 44(2), 446–456 (2008)
S.T. Lanza, M.E. Patrick, J.L. Maggs, Latent transition analysis: benefits of a latent variable approach to modeling transitions in substance use. J. Drug Issues 40(1), 93–120 (2010)
A. Connell, B.M. Bullock, T.J. Dishion, D. Shaw, M. Wilson, F. Gardner, Family intervention effects on co-occurring early childhood behavioral and emotional problems: a latent transition analysis approach. J. Abnorm. Child Psychol. 36(8), 1211–1225 (2008)
Z. Tang, H.X. Wang, C. Meng, X.G. Wu, K. Ericsson, B. Winblad, J.J. Pei, The prevalence of functional disability in activities of daily living and instrumental activities of daily living among elderly Beijing Chinese. Arch. Gerontol. Geriatr. 29(2), 115–125 (1999)
C. Chen, F.C. Lu, The guidelines for prevention and control of overweight and obesity in Chinese adults. Biomed. Environ. Sci. 17(Suppl), 1–36 (2004)
C. Barbosa-Leiker, B.R. Wright, G.L. Burns, C.D. Parks, P.S. Strand, Longitudinal measurement invariance of the metabolic syndrome: is the assessment of the metabolic syndrome stable over time? Ann. Epidemiol. 21(2), 111–117 (2011)
A. Scuteri, C.H. Morrell, S.S. Najjar, D. Muller, R. Andres, L. Ferrucci, E.G. Lakatta, Longitudinal paths to the metabolic syndrome: can the incidence of the metabolic syndrome be predicted? The baltimore longitudinal study of aging. J. Gerontol. A 64(5), 590–598 (2009)
W.S. Aronow, J.L. Fleg, C.J. Pepine, N.T. Artinian, G. Bakris, A.S. Brown, K.C. Ferdinand, M.A. Forciea, W.H. Frishman, C. Jaigobin, J.B. Kostis, G. Mancia, S. Oparil, E. Ortiz, E. Reisin, M.W. Rich, D.D. Schocken, M.A. Weber, D.J. Wesley, R.A. Harrington, ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American college of cardiology foundation task force on clinical expert consensus documents. Circulation 123(21), 2434–2506 (2011)
R. Deka, Z. Durakovic, W. Niu, G. Zhang, R. Karns, N. Smolej-Narancic, S. Missoni, D. Caric, T. Caric, D. Rudan, B. Salzer, R. Chakraborty, P. Rudan, Prevalence of metabolic syndrome and related metabolic traits in an island population of the Adriatic. Ann. Hum. Biol. 39(1), 46–53 (2012)
M. Kuzuya, F. Ando, A. Iguchi, H. Shimokata, Age-specific change of prevalence of metabolic syndrome: longitudinal observation of large Japanese cohort. Atherosclerosis 191(2), 305–312 (2007)
R. Haring, M. Rosvall, U. Volker, H. Volzke, H. Kroemer, M. Nauck, H. Wallaschofski, A network-based approach to visualize prevalence and progression of metabolic syndrome components. PLoS One 7(6), e39461 (2012)
E.S. Ford, W.H. Giles, A.H. Mokdad, Increasing prevalence of the metabolic syndrome among US adults. Diabetes Care 27(10), 2444–2449 (2004)
S.L. Gortmaker, B.A. Swinburn, D. Levy, R. Carter, P.L. Mabry, D.T. Finegood, T. Huang, T. Marsh, M.L. Moodie, Changing the future of obesity: science, policy, and action. Lancet 378(9793), 838–847 (2011)
J. Tuomilehto, P. Schwarz, J. Lindstrom, Long-term benefits from lifestyle interventions for type 2 diabetes prevention: time to expand the efforts. Diabetes Care 34(Suppl 2), S210–S214 (2011)
B.F. Zhou, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults–study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Biomed. Environ. Sci. 15(1), 83–96 (2002)
M.S. Freiberg, M.J. Pencina, R.B. D’Agostino, K. Lanier, P.W. Wilson, R.S. Vasan, BMI vs. waist circumference for identifying vascular risk. Obesity (Silver Spring) 16(2), 463–469 (2008)
F. Abbasi, C. Blasey, G.M. Reaven, Cardiometabolic risk factors and obesity: does it matter whether BMI or waist circumference is the index of obesity? Am. J. Clin. Nutr. 98(3), 637–640 (2013)
Acknowledgments
The study has been funded by the Major Project of Natural Science Fund of Beijing (Serial Number: 7131002); Key Projects in the National Science & Technology Pillar Program in the Twelfth Five-year Plan Period of China (2011BAI08B01); the Program of Natural Science Fund of China (Serial Number: 81172772); and the Program of Natural Science Fund of Beijing (Serial Number: 4112015).
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Li-Xin Tao and Wei Wang are joint first authors. They contributed equally to the work.
Rights and permissions
About this article
Cite this article
Tao, LX., Wang, W., Zhu, HP. et al. Risk profiles for metabolic syndrome and its transition patterns for the elderly in Beijing, 1992–2009. Endocrine 47, 161–168 (2014). https://doi.org/10.1007/s12020-013-0143-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-0143-4